Saltar al contenido
Merck

E3 ubiquitin ligase Cbl-b suppresses human ORMDL3 expression through STAT6 mediation.

FEBS letters (2015-06-27)
Wei-Xia Yang, Rui Jin, Chun-Ming Jiang, Xiao-Hua Wang, Jin Shu, Ling Li, Liang-Hua Zhu, Li-Li Zhuang, Chao Gao, Guo-Ping Zhou
RESUMEN

Orosomucoid 1-Like Protein 3 (ORMDL3) is an asthma candidate gene and Casitas B lineage lymphoma b (Cbl-b), an E3 ubiquitin ligase, is a critical factor in maintaining airway immune tolerance. However, the association of Cbl-b with ORMDL3 for asthma is unclear. Here, we show that expression of ORMDL3 is significantly increased and shows a strong linear correlation with decreased Cbl-b in the peripheral blood of recurrent wheeze patients. To elucidate the molecular mechanisms underlying this correlation, we identified that Cbl-b suppressed the transcriptional activity and mRNA expression of ORMDL3 in vivo. Further investigation showed that phosphorylation of signal transducer and activator of transcription 6 (STAT6) was induced by interleukin 4 bound to the ORMDL3 promoter, while Cbl-b reduced the phosphorylation of STAT6. Our results show that Cbl-b suppresses human ORMDL3 expression through STAT6.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Formaldehído solution, for molecular biology, 36.5-38% in H2O
Sigma-Aldrich
Formaldehído solution, for molecular biology, BioReagent, ≥36.0% in H2O (T)
Sigma-Aldrich
Formaldehído solution, ACS reagent, 37 wt. % in H2O, contains 10-15% Methanol as stabilizer (to prevent polymerization)
Sigma-Aldrich
Formaldehído solution, meets analytical specification of USP, ≥34.5 wt. %
Sigma-Aldrich
Formaldehyde-12C solution, 20% in H2O, 99.9 atom % 12C
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Cblb
Sigma-Aldrich
MISSION® esiRNA, targeting human CBLB